What forms do cannabis-based medicines come in?

How a medicine enters the body changes how quickly it works, how long it lasts and how predictable it is. In this field the differences between routes are unusually large, and they are one of the main things a specialist balances.

The main routes and how they differ

Three routes account for nearly all UK practice: inhalation by vaporiser, oral preparations that are swallowed, and preparations absorbed under the tongue or inside the cheek.

Many patients end up using more than one route — something longer-acting as a background, and something faster for breakthrough symptoms. That is a clinical decision made with the prescriber, and it is one that tends to be refined over the first few months rather than settled at the first appointment. The two common formats you will hear about are oils or capsules that are swallowed or held in the mouth, and dried flower that is heated in a vaporiser; a specialist chooses between them on clinical grounds, not on preference.

Why slow onset causes problems

The commonest cause of an unpleasant experience with a swallowed preparation is taking a second dose because the first did not seem to be working.

Oral absorption is slow and variable. It depends on whether you have eaten, on what you have eaten, and on individual differences in metabolism. An hour can pass with nothing apparently happening, and then both doses arrive together.

The rule that prevents this is simple and worth following literally: wait the full time your prescriber specifies before considering whether anything is needed, every time, including on days when it seems to be taking longer than usual. If a dose reliably does not seem to be working within the expected window, that is a reason to raise it with your clinic at the next contact rather than to increase it yourself. Keeping a brief note of what you took, when, and what you noticed makes that conversation far more useful than trying to recall it later.

Why smoking is not part of UK medical practice

Burning plant material produces tar, carbon monoxide and a range of combustion by-products that are irritant and carcinogenic. None of that has any therapeutic purpose.

Where an inhaled route is clinically appropriate, vaporisation is used instead: the material is heated to release the active compounds without combustion. The comparison is set out in Vaporising versus smoking.

Mixing with tobacco — still common in the UK — adds nicotine dependence and the full range of smoking-related harms on top. A prescriber will ask about this directly, and it is worth answering honestly.

How the route gets chosen

It follows from the clinical problem. Symptoms that come in episodes point one way; symptoms that are constant point another.

• Constant background symptoms — a longer-acting route usually makes more sense
• Episodic or breakthrough symptoms — a faster-acting route may suit better
• Night-time symptoms — duration matters more than speed of onset
• Respiratory disease — an inhaled route may be unsuitable
• Swallowing difficulties, nausea, or gut conditions — affect what is absorbed reliably
• Work, driving and daily commitments — duration of any impairment matters

We do not name, compare or price products anywhere on this site. UK medicines advertising law does not permit it, and that constraint is explained in Is medical cannabis legal in the UK?

How the route connects to how the medicine works

Whichever route is used, the aim is the same: to get cannabinoids into the bloodstream so they can reach the body's own endocannabinoid system, a network of receptors involved in regulating things like pain signalling, appetite, mood and sleep.

The route mostly changes the speed and the shape of that delivery, not the destination. An inhaled dose reaches the circulation quickly and then falls away; a swallowed dose arrives slowly, is processed by the liver first, and lasts longer. This is why the same daily amount can feel quite different depending on how it is taken, and why switching format is a considered change rather than a like-for-like swap. The system itself is described in more general terms in The endocannabinoid system explained, and the two most studied compounds in THC and CBD explained.

None of this predicts whether a medicine will help you. Response varies a great deal between individuals and by condition, the evidence base is limited for many uses, and some people are assessed as unsuitable for treatment altogether. The route is one variable a specialist adjusts within a treatment that is monitored as a whole.

Living with treatment day to day

The route you use has practical consequences beyond onset and duration, and these are worth thinking through before you start rather than after.

• Driving. Any impairment affects your fitness to drive, and the duration of impairment differs by route. This is covered in driving with a medical cannabis prescription.
• Work. A standard workplace drug test cannot tell a prescribed medicine from illicit use, which matters in some roles — see medical cannabis, drug testing and work.
• Travel. Carrying a controlled drug across borders has rules, and an inhaled route may draw more questions than an oil; the essentials are in travelling abroad with a prescription.
• Storage and discretion. Both formats are controlled drugs to be kept in their labelled pharmacy packaging, secured from others; how supply and storage work is set out in how medical cannabis is dispensed and delivered.

Raising these at the assessment lets a specialist weigh them into the choice of route, rather than leaving you to discover a mismatch later.

Questions worth asking your specialist

Because the route is a clinical decision, the most useful thing you can do is ask about it directly. Good questions to bring to an assessment or review include:

• Given my symptoms, which route are you suggesting, and why that one first?
• Should I expect to use more than one format, and how would they fit together?
• How long should I wait after a dose before deciding it has not worked?
• What would make you change the route rather than the amount?
• How will we review whether this is helping, and by when?

A clinician who can answer these clearly, and who builds in a point to judge the treatment, is managing it the way it should be managed.

Patient guide · Written by the Flora House editorial team · Last reviewed: 7 October 2026